1. Home
  2. TCRX vs BZUN Comparison

TCRX vs BZUN Comparison

Compare TCRX & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • BZUN
  • Stock Information
  • Founded
  • TCRX 2018
  • BZUN 2007
  • Country
  • TCRX United States
  • BZUN China
  • Employees
  • TCRX N/A
  • BZUN N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • BZUN Catalog/Specialty Distribution
  • Sector
  • TCRX Health Care
  • BZUN Consumer Discretionary
  • Exchange
  • TCRX Nasdaq
  • BZUN Nasdaq
  • Market Cap
  • TCRX 170.1M
  • BZUN 188.7M
  • IPO Year
  • TCRX 2021
  • BZUN N/A
  • Fundamental
  • Price
  • TCRX $2.40
  • BZUN $2.88
  • Analyst Decision
  • TCRX Strong Buy
  • BZUN Strong Buy
  • Analyst Count
  • TCRX 5
  • BZUN 3
  • Target Price
  • TCRX $11.40
  • BZUN $3.20
  • AVG Volume (30 Days)
  • TCRX 544.4K
  • BZUN 475.0K
  • Earning Date
  • TCRX 03-05-2025
  • BZUN 11-21-2024
  • Dividend Yield
  • TCRX N/A
  • BZUN N/A
  • EPS Growth
  • TCRX N/A
  • BZUN N/A
  • EPS
  • TCRX N/A
  • BZUN N/A
  • Revenue
  • TCRX $9,362,000.00
  • BZUN $1,312,737,613.00
  • Revenue This Year
  • TCRX N/A
  • BZUN $8.16
  • Revenue Next Year
  • TCRX $5.14
  • BZUN $4.71
  • P/E Ratio
  • TCRX N/A
  • BZUN N/A
  • Revenue Growth
  • TCRX N/A
  • BZUN 7.26
  • 52 Week Low
  • TCRX $2.38
  • BZUN $1.92
  • 52 Week High
  • TCRX $9.69
  • BZUN $4.38
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 25.27
  • BZUN 50.72
  • Support Level
  • TCRX $2.60
  • BZUN $2.75
  • Resistance Level
  • TCRX $2.85
  • BZUN $2.88
  • Average True Range (ATR)
  • TCRX 0.17
  • BZUN 0.15
  • MACD
  • TCRX 0.00
  • BZUN -0.02
  • Stochastic Oscillator
  • TCRX 2.41
  • BZUN 53.33

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About BZUN Baozun Inc.

Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).

Share on Social Networks: